125 related articles for article (PubMed ID: 34749790)
1. A lysosome-targeted dextran-doxorubicin nanodrug overcomes doxorubicin-induced chemoresistance of myeloid leukemia.
Zeng Y; Zhang X; Lin D; Feng X; Liu Y; Fang Z; Zhang W; Chen Y; Zhao M; Wu J; Jiang L
J Hematol Oncol; 2021 Nov; 14(1):189. PubMed ID: 34749790
[TBL] [Abstract][Full Text] [Related]
2. Bioactive lipids-based pH sensitive micelles for co-delivery of doxorubicin and ceramide to overcome multidrug resistance in leukemia.
Wang Y; Ding Y; Liu Z; Liu X; Chen L; Yan W
Pharm Res; 2013 Nov; 30(11):2902-16. PubMed ID: 23793993
[TBL] [Abstract][Full Text] [Related]
3. Hypoxic tumor therapy by hemoglobin-mediated drug delivery and reversal of hypoxia-induced chemoresistance.
Yang J; Li W; Luo L; Jiang M; Zhu C; Qin B; Yin H; Yuan X; Yin X; Zhang J; Luo Z; Du Y; You J
Biomaterials; 2018 Nov; 182():145-156. PubMed ID: 30121013
[TBL] [Abstract][Full Text] [Related]
4. MiR-375 delivered by lipid-coated doxorubicin-calcium carbonate nanoparticles overcomes chemoresistance in hepatocellular carcinoma.
Zhao P; Wu S; Cheng Y; You J; Chen Y; Li M; He C; Zhang X; Yang T; Lu Y; Lee RJ; He X; Xiang G
Nanomedicine; 2017 Nov; 13(8):2507-2516. PubMed ID: 28577837
[TBL] [Abstract][Full Text] [Related]
5. β3-Adrenoreceptor Blockade Reduces Hypoxic Myeloid Leukemic Cells Survival and Chemoresistance.
Calvani M; Dabraio A; Bruno G; De Gregorio V; Coronnello M; Bogani C; Ciullini S; Marca G; Vignoli M; Chiarugi P; Nardi M; Vannucchi AM; Filippi L; Favre C
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32545695
[TBL] [Abstract][Full Text] [Related]
6. Schiff base-containing dextran nanogel as pH-sensitive drug delivery system of doxorubicin: Synthesis and characterization.
Su H; Zhang W; Wu Y; Han X; Liu G; Jia Q; Shan S
J Biomater Appl; 2018 Aug; 33(2):170-181. PubMed ID: 29940809
[TBL] [Abstract][Full Text] [Related]
7. Co-Delivery of Doxorubicin and Survivin shRNA-Expressing Plasmid Via Microenvironment-Responsive Dendritic Mesoporous Silica Nanoparticles for Synergistic Cancer Therapy.
Li Z; Zhang L; Tang C; Yin C
Pharm Res; 2017 Dec; 34(12):2829-2841. PubMed ID: 28948461
[TBL] [Abstract][Full Text] [Related]
8. Ultrasmall nanostructured drug based pH-sensitive liposome for effective treatment of drug-resistant tumor.
Li Y; Zhai Y; Liu W; Zhang K; Liu J; Shi J; Zhang Z
J Nanobiotechnology; 2019 Nov; 17(1):117. PubMed ID: 31783863
[TBL] [Abstract][Full Text] [Related]
9. Cucumber mosaic virus as drug delivery vehicle for doxorubicin.
Zeng Q; Wen H; Wen Q; Chen X; Wang Y; Xuan W; Liang J; Wan S
Biomaterials; 2013 Jun; 34(19):4632-42. PubMed ID: 23528229
[TBL] [Abstract][Full Text] [Related]
10. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X
Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771
[TBL] [Abstract][Full Text] [Related]
11. Fullerene (C60)-based tumor-targeting nanoparticles with "off-on" state for enhanced treatment of cancer.
Shi J; Wang B; Wang L; Lu T; Fu Y; Zhang H; Zhang Z
J Control Release; 2016 Aug; 235():245-258. PubMed ID: 27276066
[TBL] [Abstract][Full Text] [Related]
12. Enhanced anti-tumor effect of pH-responsive dextrin nanogels delivering doxorubicin on colorectal cancer.
Manchun S; Dass CR; Cheewatanakornkool K; Sriamornsak P
Carbohydr Polym; 2015 Aug; 126():222-30. PubMed ID: 25933543
[TBL] [Abstract][Full Text] [Related]
13. ROS-sensitive thioketal-linked polyphosphoester-doxorubicin conjugate for precise phototriggered locoregional chemotherapy.
Pei P; Sun C; Tao W; Li J; Yang X; Wang J
Biomaterials; 2019 Jan; 188():74-82. PubMed ID: 30336287
[TBL] [Abstract][Full Text] [Related]
14. Nanometronomic treatment of 4T1 breast cancer with nanocaged doxorubicin prevents drug resistance and circumvents cardiotoxicity.
Mazzucchelli S; Bellini M; Fiandra L; Truffi M; Rizzuto MA; Sorrentino L; Longhi E; Nebuloni M; Prosperi D; Corsi F
Oncotarget; 2017 Jan; 8(5):8383-8396. PubMed ID: 28039473
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-responsive polymeric nanoparticles for tumor-targeted drug delivery.
Thambi T; Deepagan VG; Yoon HY; Han HS; Kim SH; Son S; Jo DG; Ahn CH; Suh YD; Kim K; Kwon IC; Lee DS; Park JH
Biomaterials; 2014 Feb; 35(5):1735-43. PubMed ID: 24290696
[TBL] [Abstract][Full Text] [Related]
16. Glucose Modulation Induces Lysosome Formation and Increases Lysosomotropic Drug Sequestration via the P-Glycoprotein Drug Transporter.
Seebacher NA; Lane DJ; Jansson PJ; Richardson DR
J Biol Chem; 2016 Feb; 291(8):3796-820. PubMed ID: 26601947
[TBL] [Abstract][Full Text] [Related]
17. Multifunctional aptamer-based nanoparticles for targeted drug delivery to circumvent cancer resistance.
Liu J; Wei T; Zhao J; Huang Y; Deng H; Kumar A; Wang C; Liang Z; Ma X; Liang XJ
Biomaterials; 2016 Jun; 91():44-56. PubMed ID: 26994877
[TBL] [Abstract][Full Text] [Related]
18. Versatile preparation of intracellular-acidity-sensitive oxime-linked polysaccharide-doxorubicin conjugate for malignancy therapeutic.
Xu W; Ding J; Xiao C; Li L; Zhuang X; Chen X
Biomaterials; 2015 Jun; 54():72-86. PubMed ID: 25907041
[TBL] [Abstract][Full Text] [Related]
19. Riboflavin-containing telodendrimer nanocarriers for efficient doxorubicin delivery: High loading capacity, increased stability, and improved anticancer efficacy.
Guo D; Shi C; Wang X; Wang L; Zhang S; Luo J
Biomaterials; 2017 Oct; 141():161-175. PubMed ID: 28688287
[TBL] [Abstract][Full Text] [Related]
20. Effect of silver nanoparticles synthesized by gamma radiation on the cytotoxicity of doxorubicin in human cancer cell lines and experimental animals.
Mansour HH; Eid M; El-Arnaouty MB
Hum Exp Toxicol; 2018 Jan; 37(1):38-50. PubMed ID: 28116921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
